[HTML][HTML] Colorectal cancer biomarkers in the era of personalized medicine
JN Patel, MK Fong, M Jagosky - Journal of personalized medicine, 2019 - mdpi.com
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
Colorectal Cancer Biomarkers in the Era of Personalized Medicine
JN Patel, MK Fong, M Jagosky - Journal of Personalized …, 2019 - search.proquest.com
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
[HTML][HTML] Colorectal Cancer Biomarkers in the Era of Personalized Medicine
JN Patel, MK Fong, M Jagosky - Journal of Personalized Medicine, 2019 - ncbi.nlm.nih.gov
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
Colorectal Cancer Biomarkers in the Era of Personalized Medicine.
JN Patel, MK Fong, M Jagosky - Journal of Personalized …, 2019 - search.ebscohost.com
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
[PDF][PDF] Colorectal Cancer Biomarkers in the Era of Personalized Medicine
JN Patel, MK Fong, M Jagosky - academia.edu
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
Colorectal Cancer Biomarkers in the Era of Personalized Medicine.
JN Patel, MK Fong, M Jagosky - Journal of Personalized Medicine, 2019 - europepmc.org
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
[PDF][PDF] Colorectal Cancer Biomarkers in the Era of Personalized Medicine
JN Patel, MK Fong, M Jagosky - pdfs.semanticscholar.org
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …
Colorectal Cancer Biomarkers in the Era of Personalized Medicine
JN Patel, MK Fong, M Jagosky - Journal of personalized …, 2019 - pubmed.ncbi.nlm.nih.gov
The 5-year survival probability for patients with metastatic colorectal cancer has not
drastically changed over the last several years, nor has the backbone chemotherapy in first …
drastically changed over the last several years, nor has the backbone chemotherapy in first …